Evotec SE (EVO) Exchange Rate Effect (2009 - 2026)
Evotec SE (EVO) reported Exchange Rate Effect of $5660.6 for Q1 2026, up 277.95% on a YoY basis from $1497.7 in Q1 2025, and up 100.04% sequentially from -$14.7 million in Q4 2025.
Evotec SE (EVO) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 9 years of Exchange Rate Effect data on file, last reported at $5660.6 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 277.95% year-over-year to $5660.6; the trailing twelve-month figure through Mar 2026 stood at -$14.7 million (down 239.68% YoY), and the FY2025 full-year result was -$14.7 million, down 239.69% from the prior year.
- Exchange Rate Effect climbed to $5660.6 in Q1 2026, from -$14.7 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $10.5 million in Q4 2024 to a low of -$19.4 million in Q4 2022.
- A 5-year average of -$1.3 million and a median of -$88.96 in 2024 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 1629.02% in 2022, while the deepest fall reached 24595.19% in 2022.
- Tracing EVO's Exchange Rate Effect over 5 years: stood at -$19.4 million in 2022, then surged by 103.55% to $690595.3 in 2023, then jumped by 1427.15% to $10.5 million in 2024, then slumped by 239.51% to -$14.7 million in 2025, then jumped by 100.04% to $5660.6 in 2026.
- Business Quant data shows EVO's Exchange Rate Effect at $5660.6 in Q1 2026, -$14.7 million in Q4 2025, and -$1895.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | 5,660.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,660.56 |
| Mar 31, 2026 | 5,660.56 |
| Dec 31, 2025 | -14.71 Mn |
| Dec 31, 2025 | -14.71 Mn |
| Sep 30, 2025 | -1,895.04 |
| Sep 30, 2025 | -1,895.04 |
| Jun 30, 2025 | -8,453.47 |
| Jun 30, 2025 | -8,453.47 |
| Mar 31, 2025 | -3,180.90 |
| Mar 31, 2025 | -3,180.90 |
| Dec 31, 2024 | 10.55 Mn |
| Dec 31, 2024 | 10.55 Mn |
| Sep 30, 2024 | -88.96 |
| Sep 30, 2024 | -88.96 |
| Jun 30, 2024 | -6,122.11 |
| Jun 30, 2024 | -6,122.11 |
| Mar 31, 2024 | 2,561.64 |
| Mar 31, 2024 | 2,561.64 |
| Dec 31, 2023 | 690,595.26 |
| Dec 31, 2023 | 690,595.26 |